⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PHIO News
Phio Pharmaceuticals Corp. Common Stock
Sidoti Events, LLC's January Micro-Cap Virtual Conference
accessnewswire.com
KLTR
AP
NTIC
ODYS
NEOV
SBC
HOFT
SPCB
STRR
UPXI
LGL
PHIO
DAKT
TII
KGEI
MFIN
Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference January 21-22, 2026 Ready to Announce with Confidence?
newsfilecorp.com
PHIO
Phio Pharmaceuticals Announces Significant Step Forward in its Drug Development Program for PH-762 Ready to Announce with Confidence?
newsfilecorp.com
PHIO
Phio Pharmaceuticals Announces Appointment of Mr. David H. Deming to the Position of Lead Independent Director
newsfilecorp.com
PHIO
Phio Pharmaceuticals Announces Completion of Enrollment in Phase 1b Clinical Trial of INTASYL siRNA Lead Compound PH-762
newsfilecorp.com
PHIO
Phio Pharmaceuticals Announces Upcoming Podium Presentation at the Advanced Therapies USA 2025 Congress
newsfilecorp.com
PHIO
Phio Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
newsfilecorp.com
PHIO
Phio Pharmaceuticals to Present Recent Clinical Results from Skin Cancer Trial with siRNA based INTASYL PH-762
newsfilecorp.com
PHIO
Phio Pharmaceuticals Announces INTASYL PH-762 is Named Immunomodulatory Solution of the Year in the BioTech Breakthrough Award Program
newsfilecorp.com
PHIO
Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $13.4 Million Gross Proceeds
newsfilecorp.com
PHIO